DK69887A - Dichloranilinderivater - Google Patents
DichloranilinderivaterInfo
- Publication number
- DK69887A DK69887A DK069887A DK69887A DK69887A DK 69887 A DK69887 A DK 69887A DK 069887 A DK069887 A DK 069887A DK 69887 A DK69887 A DK 69887A DK 69887 A DK69887 A DK 69887A
- Authority
- DK
- Denmark
- Prior art keywords
- dichloraniline
- derivatives
- dichloraniline derivatives
- Prior art date
Links
- DADSZOFTIIETSV-UHFFFAOYSA-N n,n-dichloroaniline Chemical class ClN(Cl)C1=CC=CC=C1 DADSZOFTIIETSV-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8603475 | 1986-02-12 | ||
| GB868603475A GB8603475D0 (en) | 1986-02-12 | 1986-02-12 | Chemical compounds |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK69887D0 DK69887D0 (da) | 1987-02-11 |
| DK69887A true DK69887A (da) | 1987-08-13 |
| DK163991B DK163991B (da) | 1992-04-27 |
| DK163991C DK163991C (da) | 1992-09-21 |
Family
ID=10592944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK069887A DK163991C (da) | 1986-02-12 | 1987-02-11 | Dichloranilinderivater, fremgangsmaade til fremstilling af disse, samt farmaceutiske praeparater indeholdende derivaterne |
Country Status (37)
| Country | Link |
|---|---|
| US (1) | US4937251A (da) |
| JP (2) | JPS62258359A (da) |
| KR (1) | KR870007886A (da) |
| CN (1) | CN1020095C (da) |
| AT (1) | AT394364B (da) |
| AU (1) | AU596824B2 (da) |
| BE (1) | BE1002129A3 (da) |
| CA (1) | CA1301762C (da) |
| CH (1) | CH670636A5 (da) |
| CS (1) | CS402991A3 (da) |
| CY (1) | CY1660A (da) |
| DE (1) | DE3704223C2 (da) |
| DK (1) | DK163991C (da) |
| ES (1) | ES2004676A6 (da) |
| FI (1) | FI83774C (da) |
| FR (1) | FR2596049B1 (da) |
| GB (2) | GB8603475D0 (da) |
| GR (1) | GR870220B (da) |
| HK (1) | HK85790A (da) |
| HU (1) | HU199416B (da) |
| IE (1) | IE59524B1 (da) |
| IL (2) | IL81535A (da) |
| IS (1) | IS1489B (da) |
| IT (1) | IT1205978B (da) |
| LU (1) | LU86768A1 (da) |
| MX (1) | MX5220A (da) |
| NL (1) | NL188408C (da) |
| NO (1) | NO170629C (da) |
| NZ (1) | NZ219241A (da) |
| PH (1) | PH24067A (da) |
| PL (1) | PL151050B1 (da) |
| PT (1) | PT84273B (da) |
| SE (1) | SE462562B (da) |
| SG (1) | SG70590G (da) |
| SU (1) | SU1590042A3 (da) |
| ZA (1) | ZA87974B (da) |
| ZW (1) | ZW2887A1 (da) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8703007D0 (en) * | 1987-02-10 | 1987-03-18 | Glaxo Group Ltd | Chemical compounds |
| US5149698A (en) * | 1987-08-11 | 1992-09-22 | Glaxo Group Limited | Chloroaniline derivatives |
| GB8718939D0 (en) * | 1987-08-11 | 1987-09-16 | Glaxo Group Ltd | Chemical compounds |
| JPH0228141A (ja) * | 1987-11-13 | 1990-01-30 | Glaxo Group Ltd | フェネタノールアミン誘導体 |
| AT399874B (de) * | 1990-06-05 | 1995-08-25 | Glaxo Group Ltd | Dichloranilinverbindung |
| GB9104650D0 (en) * | 1991-03-05 | 1991-04-17 | Glaxo Group Ltd | Medicaments |
| US6419873B1 (en) | 1999-03-19 | 2002-07-16 | Q2100, Inc. | Plastic lens systems, compositions, and methods |
| US6436972B1 (en) | 2000-04-10 | 2002-08-20 | Dalhousie University | Pyridones and their use as modulators of serine hydrolase enzymes |
| TWI249515B (en) | 2001-11-13 | 2006-02-21 | Theravance Inc | Aryl aniline beta2 adrenergic receptor agonists |
| DE10392748B4 (de) * | 2002-06-18 | 2010-12-23 | Asahi Kasei Emd Corporation | Strommessverfahren und Strommessvorrichtung |
| US20070219223A1 (en) * | 2006-03-07 | 2007-09-20 | Endacea, Inc. | Compositions and methods for treating respiratory disorders |
| JP5626621B2 (ja) | 2010-03-19 | 2014-11-19 | 株式会社 日立産業制御ソリューションズ | フェイズドアレイ合成開口ソナーシステム |
| HK1203412A1 (en) | 2011-12-28 | 2015-10-30 | Global Blood Therapeutics, Inc. | Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation |
| JP6242810B2 (ja) | 2011-12-28 | 2017-12-06 | グローバル・ブラッド・セラピューティクス・インコーポレイテッドＧｌｏｂａｌ Ｂｌｏｏｄ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | 置換ベンズアルデヒド化合物および組織酸素化の増加におけるそれらの使用方法 |
| US20140274961A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| WO2014150276A1 (en) | 2013-03-15 | 2014-09-25 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US10100043B2 (en) | 2013-03-15 | 2018-10-16 | Global Blood Therapeutics, Inc. | Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation |
| US9802900B2 (en) | 2013-03-15 | 2017-10-31 | Global Blood Therapeutics, Inc. | Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
| US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9604999B2 (en) | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| SG11201507453VA (en) | 2013-03-15 | 2015-10-29 | Global Blood Therapeutics Inc | Compounds and uses thereof for the modulation of hemoglobin |
| PE20161035A1 (es) | 2013-03-15 | 2016-11-13 | Global Blood Therapeutics Inc | Compuestos y usos de estos para la modulacion de la hemoglobina |
| EA201992707A1 (ru) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
| HRP20210388T4 (hr) | 2014-02-07 | 2024-10-11 | Global Blood Therapeutics, Inc. | Kristalni polimorf slobodne baze od 2-hidroksi-6-((2-(1-izopropil-1h-pirazol-5-il)piridin-3-il)metoksi)benzaldehida |
| MA41841A (fr) | 2015-03-30 | 2018-02-06 | Global Blood Therapeutics Inc | Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs |
| SG11201804647TA (en) | 2015-12-04 | 2018-06-28 | Global Blood Therapeutics Inc | Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
| TWI663160B (zh) | 2016-05-12 | 2019-06-21 | 全球血液治療公司 | 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法 |
| TW202332423A (zh) | 2016-10-12 | 2023-08-16 | 美商全球血液治療公司 | 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑 |
| ES2966707T3 (es) | 2018-10-01 | 2024-04-23 | Global Blood Therapeutics Inc | Moduladores de la hemoglobina para el tratamiento de la drepanocitosis |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1618005A1 (de) * | 1966-09-22 | 1971-09-09 | Thomae Gmbh Dr K | Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen |
| NL176168C (nl) * | 1972-12-18 | 1985-03-01 | Thomae Gmbh Dr K | Werkwijze ter bereiding respectievelijk vervaardiging van een farmaceutisch preparaat en werkwijze ter bereiding van daarbij bruikbare nieuwe gesubstitueerde 1-(4-aminofenyl)-2-amino-ethanol-derivaten die, behalve een analgetische, uterusspasmolytische en anti-spastische werking op de dwarsgestreepte spieren, in het bijzonder een beta2-mimetische en/of beta1-blokkerende werking bezitten. |
| DE2711655A1 (de) * | 1977-03-17 | 1978-09-21 | Basf Ag | Pyridinyl-aminoalkylaether |
| CH635320A5 (en) * | 1978-01-01 | 1983-03-31 | Ciba Geigy Ag | 1-(Azacyclic aralkoxyphenyl)-2- or -3-(bis-arylalkylamino)alkanes |
| DE3061205D1 (en) * | 1979-06-16 | 1983-01-05 | Beecham Group Plc | Secondary amines, their preparation and use in pharmaceutical compositions |
| NL8105170A (nl) * | 1980-12-10 | 1982-07-01 | Thomae Gmbh Dr K | Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen. |
| US4379166A (en) * | 1981-08-03 | 1983-04-05 | Schering Corporation | Arylmethoxy-, arylmethylthio-, heteroarylmethoxy-, and heteroarylmethylthio-alkylaminoalcohols |
| HU186654B (en) * | 1982-12-28 | 1985-09-30 | Richter Gedeon Vegyeszet | Process for producing new pyridine derivatives, acid additional salts and quaternary salts and pharmaceutical compositions containing them |
| DE3434271A1 (de) * | 1984-09-19 | 1986-03-20 | Beiersdorf Ag, 2000 Hamburg | Substituierte 3,4-dihydro-chinolin-2(1h)-one verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen |
| GB8426191D0 (en) * | 1984-10-17 | 1984-11-21 | Glaxo Holdings Ltd | Chemical compounds |
| GB8525484D0 (en) * | 1985-10-16 | 1985-11-20 | Glaxo Group Ltd | Chemical compounds |
| GB8718939D0 (en) * | 1987-08-11 | 1987-09-16 | Glaxo Group Ltd | Chemical compounds |
-
1986
- 1986-02-12 GB GB868603475A patent/GB8603475D0/en active Pending
-
1987
- 1987-02-10 GR GR870220A patent/GR870220B/el unknown
- 1987-02-10 IS IS3193A patent/IS1489B/is unknown
- 1987-02-11 FR FR878701698A patent/FR2596049B1/fr not_active Expired - Fee Related
- 1987-02-11 NO NO870526A patent/NO170629C/no unknown
- 1987-02-11 PL PL1987264054A patent/PL151050B1/pl unknown
- 1987-02-11 BE BE8700109A patent/BE1002129A3/fr not_active IP Right Cessation
- 1987-02-11 AU AU68695/87A patent/AU596824B2/en not_active Ceased
- 1987-02-11 SE SE8700535A patent/SE462562B/sv not_active IP Right Cessation
- 1987-02-11 CH CH527/87A patent/CH670636A5/fr not_active IP Right Cessation
- 1987-02-11 PH PH34850A patent/PH24067A/en unknown
- 1987-02-11 GB GB8703059A patent/GB2187734B/en not_active Expired - Fee Related
- 1987-02-11 PT PT84273A patent/PT84273B/pt not_active IP Right Cessation
- 1987-02-11 HU HU87530A patent/HU199416B/hu not_active IP Right Cessation
- 1987-02-11 IT IT47630/87A patent/IT1205978B/it active
- 1987-02-11 NZ NZ219241A patent/NZ219241A/en unknown
- 1987-02-11 LU LU86768A patent/LU86768A1/fr unknown
- 1987-02-11 AT AT0028687A patent/AT394364B/de not_active IP Right Cessation
- 1987-02-11 SU SU874202054A patent/SU1590042A3/ru active
- 1987-02-11 ES ES8700341A patent/ES2004676A6/es not_active Expired
- 1987-02-11 IL IL81535A patent/IL81535A/xx not_active IP Right Cessation
- 1987-02-11 US US07/013,895 patent/US4937251A/en not_active Expired - Fee Related
- 1987-02-11 ZA ZA87974A patent/ZA87974B/xx unknown
- 1987-02-11 NL NLAANVRAGE8700326,A patent/NL188408C/xx not_active IP Right Cessation
- 1987-02-11 DE DE3704223A patent/DE3704223C2/de not_active Expired - Fee Related
- 1987-02-11 ZW ZW28/87A patent/ZW2887A1/xx unknown
- 1987-02-11 DK DK069887A patent/DK163991C/da active
- 1987-02-11 CN CN87101830A patent/CN1020095C/zh not_active Expired - Fee Related
- 1987-02-11 IE IE35087A patent/IE59524B1/en not_active IP Right Cessation
- 1987-02-11 FI FI870554A patent/FI83774C/fi not_active IP Right Cessation
- 1987-02-12 CA CA000529552A patent/CA1301762C/en not_active Expired - Fee Related
- 1987-02-12 JP JP62030644A patent/JPS62258359A/ja active Granted
- 1987-02-12 MX MX522087A patent/MX5220A/es unknown
- 1987-02-12 KR KR870001162A patent/KR870007886A/ko not_active Ceased
-
1989
- 1989-02-07 IL IL89205A patent/IL89205A/xx not_active IP Right Cessation
-
1990
- 1990-05-21 JP JP2131124A patent/JPH0314565A/ja active Pending
- 1990-08-24 SG SG705/90A patent/SG70590G/en unknown
- 1990-10-18 HK HK857/90A patent/HK85790A/xx not_active IP Right Cessation
-
1991
- 1991-12-23 CS CS914029A patent/CS402991A3/cs unknown
-
1993
- 1993-05-14 CY CY1660A patent/CY1660A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK263587D0 (da) | Imidazoquinolinyletherderivater | |
| DK82087D0 (da) | Pyrocatecholderivater | |
| DK69887A (da) | Dichloranilinderivater | |
| ATA312487A (de) | Tetrahydrocarbazolonderivate | |
| AT399804B (de) | Sportschuh | |
| ES2024442B3 (es) | Segadora-trilladora | |
| TR26815A (tr) | Azolilmetil-sikropil türevleri | |
| TR24894A (tr) | N-FENILPIRAZOL TüREVLERI | |
| DK507188A (da) | Cholecalciferolderivater | |
| DK693587A (da) | Alkansulfonanilidderivater | |
| DK81888D0 (da) | Dibenzoxepinderivater | |
| DK378088D0 (da) | Alkenderivater | |
| DK49688A (da) | Propiolophenonderivater | |
| DK691287D0 (da) | 5-floururacilderivater | |
| DK210487D0 (da) | Substituerede benzimidazolderivater | |
| NO171837C (no) | Fartoey | |
| DK444687D0 (da) | Alfa-substituerede ketonitron-derivater | |
| DK271088D0 (da) | Tienopyridinderivater | |
| DK229887A (da) | Alkenamidderivater | |
| DK619187A (da) | Isoindolderivater | |
| DK440687A (da) | Bicyclooctanderivater | |
| DK695788A (da) | Naphtalenderivater | |
| DK435087A (da) | Isoprenderivater | |
| DK440787D0 (da) | Bicyclooctanderivater | |
| DK71488D0 (da) | Dipenylethylen-derivater |